Dr. Lawrence Moon is a Senior Lecturer and Principal Investigator at the Wolfson Centre for Age-Related Diseases @ King’s College, London (University of London).
He has received funding from the Research Councils’ UK, the British Pharmacological Society, the Medical Research Council, the BBSRC, the Royal Society, the Henry Smith Charity, the Dowager Countess Eleanor Peel Trust, the Friends of Guy's, and King’s College, London.
His research aims to identify methods for promoting axon growth and recovery of function after spinal cord injury and stroke.
- 2012: Senior Lecturer, Department of Pharmacology & Principal Investigator, Wolfson Centre for Age-Related Diseases, King's College London.
- 2010 - 2012: Lecturer, Department of Pharmacology & Principal Investigator, Wolfson Centre for Age-Related Diseases, King's College London.
- 2005 - 2010: Research Councils UK Academic Fellow.Wolfson Centre for Age-Related Diseases, King's College London.
- 2001 - 2005: Miami Project to Cure Paralysis, Miller School of Medicine, University of Miami. Postdoctoral researcher in lab of Professor Mary Bartlett Bunge. Associate member of Christopher Reeve Paralysis Foundation’s International Research Consortium.
- 1997 - 2001: Queens’ College, University of Cambridge. MRC Centre for Brain Repair. Ph.D., Laboratory of Prof. James Fawcett.
- 1993 - 1997: Top First, B.A. (Hons), Scholar, Jesus College, University of Oxford. Psychology, Physiology and Philosophy.
- 1992 - 1993: Royal Corps of Signals, British Army.
- Thuret S, Moon LDF and Gage FH (2006) Therapeutic strategies for SCI. Nature Reviews Neuroscience 7:628-643.
- Bradbury EJ, Moon LDF, Popat RJ, King VR, Bennett GS, Patel PN, Priestley JV, Fawcett JW, McMahon SB (2002) Chondroitinase ABC promotes axon regeneration and functional recovery following spinal cord injury. Nature 416:636-40.
- Moon LDF, Asher RA, Rhodes KE, Fawcett JW (2001) Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nature Neuroscience 4:465-466.